An interventional study of Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2 in Emotional Distress, Cardiac Arrest (CA) and Anxiety, sponsored by Icahn School of Medicine at Mount Sinai. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Treatment
The purpose of this study is to pilot two resilience interventions for cardiac arrest survivors and their informal caregivers, Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2 . The data the investigators gather in this study will be used to further refine the interventions.
The goal of this study is to test the feasibility of the proposed interventions through a pilot RCT. The investigators will deliver the RCT intervention (N=42 dyads; 84 participants total) and evaluate feasibility and acceptability based on a priori benchmarks.
The RCT takes place initially in intensive care units and step-down units then progresses to Zoom once survivors are discharged. Cardiac arrest survivor-caregiver dyads will be randomly assigned to one of two groups - Recovering Together after Cardiac Arrest 1 (RT-CA 1) or Recovering Together after Cardiac Arrest 2 (RT-CA 2).
RT-CA 1 involves six, 30-minute weekly sessions beginning at bedside and continuing over Zoom after the survivor is discharged. RT-CA 2 involves one, 30 minute session at bedside.
All participants will complete psychosocial survey measures at baseline, six weeks, and 3 months.
966 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
This study's planned enrollment of 84 is below the median of 100 across 557 interventional studies indexed under Heart Arrest.
Browse Heart Arrest studies →Icahn School of Medicine at Mount Sinai is the lead sponsor of 764 studies on the registry; 181 are open to participants now.
Of its 121 completed or terminated interventional studies of FDA-regulated products, 82 (68%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Dyads will participate in 6 30-minute skills-based sessions. Sessions will also include provision of anticipatory guidance and resources to manage cardiac arrest-specific stressors. A clinical psychologist will deliver all of the sessions. The main intervention goal is to provide dyads with resiliency skills and resources to reduce emotional distress and prevent chronic distress.
Behavioral: Recovering Together after Cardiac Arrest 1
Recovering Together after Cardiac Arrest is a minimally enhanced usual care control. Dyads will participate in one 30-minute session with a clinician reviewing available psychosocial resources for cardiac arrest survivors and their caregivers.
Other: Recovering Together after Cardiac Arrest 2
The intervention will teach resiliency skills (mindfulness and coping) to dyads and provider anticipatory guidance and resources to manage stressors specific to cardiac arrest. These sessions will take place in person until the survivor is discharged; remaining sessions will occur over Zoom.
In this minimally enhanced usual care control, dyads will participate in one 30-minute session with a clinician at beside to review a pamphlet of available psychosocial resources for cardiac arrest survivors and their caregivers.
Feasibility of Recruitment
Proportion of eligible dyads that consent to participation
Time frame: pre-test
Feasibility of Randomization
Proportion of randomized participants who submit post-test assessments
Time frame: The end of treatment at 6 weeks
Feasibility of Assessment Completion
Proportion of participants with no assessment measures missing at pre-test, post-test, and 3 month follow-up
Time frame: pre-test, the end of treatment at 6 weeks, and 3 months after the end of treatment
Feasibility of Program Adherence (RT-CA 1)
Proportion of RT-CA 1 dyads that initiate the program by attending session 1 and complete at least 4 of 6 sessions.
Time frame: the end of treatment at 6 weeks
Therapist Fidelity
Proportion of 20% randomly-selected RT-CA 1 sessions in which the therapist fully adheres to program content, ascertained by a fidelity checklist
Time frame: the end of treatment at 6 weeks
Treatment Satisfaction (RT-CA 1)
Proportion of RT-CA 1 participants that endorse satisfaction, defined as above the midpoint on the Client Satisfaction Questionnaire-3
Time frame: the end of treatment at 6 weeks
Credibility (RT-CA 1)
Proportion of RT-CA 1 participants that endorse program credibility at pre-test, defined as scoring above the midpoint on the Credibility sub scale of the Credibility/Expectancy Questionnaire which is scored from 3-27; higher scores indicate greater credibility.
Time frame: pre-test
Expectancy (RT-CA 1)
Proportion of RT-CA 1 participants that endorse expectancy to improve. from the program at pre-test, defined as scoring above the midpoint on the Expectancy sub scale of the Credibility/Expectancy Questionnaire which is scored from 3-27; higher scores indicate greater expectancy.
Time frame: pre-test
Study safety
The proportion of participants that report no adverse events related to study participation.
Time frame: at the end of treatment at 6 weeks and 3 months after the end of treatment
Plan to share: Yes — De-identified data will be shared upon reasonable request.
Supporting information: Study protocol, Icf, Analytic code
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Icahn School of Medicine at Mount Sinai